Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Pattern of timing adherence could guide recommendations for personalized intake schedules
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1477997
Author(s) Walter, Philipp; Arnet, Isabelle; Romanens, Michel; Tsakiris, Dimitrios A; Hersberger, Kurt E
Author(s) at UniBasel Arnet, Isabelle
Walter, Philipp
Hersberger, Kurt
Tsakiris, Dimitrios
Year 2012
Title Pattern of timing adherence could guide recommendations for personalized intake schedules
Journal Journal of personalized medicine
Volume 2
Number 4
Pages / Article-Number 267-76
Keywords compliance; adherence; time variability; electronic polymedication monitoring; lipid lowering agents
Abstract

Deviations in execution from the prescribed drug intake schedules (timing non adherence) are frequent and may pose a substantial risk for therapeutic failure. Simple methods to monitor timing adherence with multiple drugs are missing. A new technology, i.e., the polymedication electronic monitoring system (POEMS) attached to a multidrug punch card, was used in a clinical trial on outpatients with prescribed medicines for vascular risk reduction. The complete delineation of timing adherence allows for the calculation of objective adherence parameters and the linking of exposure with drug-drug interactions. A sub-analysis was performed on 68 patients, who were prescribed lipid lowering therapy. A smaller intake time variability of the lipid lowering drug was significantly associated with better levels of LDL-cholesterol, independently of the time of day. This finding may challenge current general recommendations for the timing of lipid lowering drugs’ intake and substantiate that inter-individual differences in timing adherence may contribute to response variability. Thus, objective parameters based on multidrug adherence monitoring should be considered as independent variables in personalized medicine. In clinical practice, personalized intake recommendations according to patients’ pattern of timing adherence may help to optimize the effectiveness of lipid lowering agents.

Publisher MDPI
edoc-URL http://edoc.unibas.ch/dok/A6056299
Full Text on edoc No
Digital Object Identifier DOI 10.3390/jpm2040267
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/25562364
ISI-Number MEDLINE:25562364
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.323 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
13/04/2024